Thermo Fisher Scientific | TMO - Заемный капитал





Заемный капитал Изменить Дата
Abbott USD 29.64B 19.74B 2026-03
Agilent USD 3.64B 594M 2026-06
Becton, Dickinson and Co. USD 13.51B 1.2B 2026-06
Bio Techne USD 200M 60M 2026-03
Bio-Rad Laboratories USD 803M 100K 2026-06
Boston Scientific USD 10.86B 148M 2026-03
Bruker USD 1.81B 151.8M 2026-06
Charles River Laboratories USD 2.62B 43.15M 2026-06
Danaher USD 25.15B 7.59B 2026-06
Dentsply International USD 2B 10M 2026-06
Edwards Lifesciences USD 598.7M 1.3M 2026-06
General Electric Aerospace USD 17.16B 1.02B 2026-06
Henry Schein USD 2.3B 27M 2026-06
Illumina USD 1.49B 1000K 2026-06
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 13.7B 284M 2026-06
Laboratory Of America USD 5.92B 23.3M 2026-06
Medtronic USD 26.12B 1.76B 2026-03
Mettler Toledo International USD 2.04B 116.92M 2026-06
Myriad Genetics USD 120.7M 400K 2026-06
Olympus JPY 179.76B 20.07B 2026-06
OraSure Technologies USD 100K 17K 2025-12
Quest Diagnostics USD 5.63B 477M 2026-06
Repligen USD 551.05M 4.46M 2026-06
Revvity USD 2.63B 1.02M 2026-06
Stryker USD 14.19B 32M 2026-06
Thermo Fisher Scientific USD 39.18B 890M 2026-06
Veracyte USD 0 0 2025-03
Waters USD 5.09B 129M 2026-06
Zimmer Biomet Holdings USD 6.28B 17.6M 2026-06